Article
Mutation informatics: SARS-CoV-2 receptor-binding domain of the spike protein.
Drug discovery today - 1 Oct 2022
Verma Saroj, Patil Vaishali M, Gupta Manish K
Abstract excerpt
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) undergoes mutations at a high rate and with frequent genetic reassortment (antigenic drift/shift), leading to variability in targets. The receptor-binding domain (RBD) of the spike (S) protein has a major role in the binding of SARS-CoV-2 with human angiotensin-converting enzyme 2 (ACE2). Mutations at the RBD influence the binding interaction at the...
Topics
Join the communities discussing this publication.
